Public Data
6 samples
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [RNA-Seq 2]
Accession: SRP403295
Published: 2024 in Sci Transl Med
cell line
bioactive entity
prostate gland
prostate cancer
Public Data
4 samples
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [22Rv1sgCD276]
Accession: SRP404909
Published: 2024 in Sci Transl Med
cell line
gene, gene: crispr
prostate gland
prostate cancer
Public Data
9 samples
DNA methylation as a therapeutic target in RB1 deficient and neuroendocrine prostate cancer and rational co-targeting with B7-H3 [RNA-Seq 1]
Accession: SRP403294
Published: 2024 in Sci Transl Med
cell line
gene, gene: crispr
prostate gland
prostate cancer
Public Data
130 samples
Circulating Cell-Free RNA in Blood as a Host Response Biomarker for the Detection of Tuberculosis [training_data]
Accession: SRP498188
Published: 2024 in Nat Commun
primary cells, primary tissue
blood, plasma
tuberculosis
Public Data
1 sample
425-panel-NGS in patients with primary lung cancer with breast metastases
Accession: SRP498185
Published: 2024
primary tissue
breast
Public Data
12 samples
Long noncoding RNAs expression profiles in granulosa of woman with diminished ovarian reserve based on high-throughput sequencing
Accession: SRP353766
Published: 2024 in J Ovarian Res
primary cells
ovary
normal
Public Data
6 samples
Study of the eIFG1-eIF1 interaction by TCP-seq on translation initiation in HEK 293T cells
Accession: SRP424622
Published: 2024 in Cell Rep
cell line
bioactive entity
kidney
Public Data
5 samples
GEO accession GSE221263 is currently private and is scheduled to be released on Jan 01, 2025.
Accession: SRP414239
Published: 2024
cell line
gene, gene: overexpression
prostate gland
prostate cancer
Public Data
4 samples
GEO accession GSE262226 is currently private and is scheduled to be released on Mar 27, 2024.
Accession: SRP497249
Published: 2024
cell line
bioactive entity
breast
triple-negative breast carcinoma
Public Data
8 samples
GEO accession GSE262085 is currently private and is scheduled to be released on Mar 27, 2024.
Accession: SRP496775
Published: 2024 in JCI Insight
cell line
gene, gene: overexpression
colon
colorectal cancer
Public Data
6 samples
Gene expression of sphere-derived prostate cancer stem cells
Accession: SRP429279
Published: 2024
cell line
other
prostate gland
prostate cancer
Public Data
6 samples
Ethyl Acetate Extract of Antenoron Filiforme Inhibits the Proliferation of Triple Negative Breast Cancer Cell via Suppressing SKP2/P21 Signaling Axis
Accession: SRP429576
Published: 2024 in Phytomedicine
cell line
bioactive entity
breast
triple-negative breast carcinoma
Public Data
7 samples
Homo sapiens Raw sequence reads
Accession: SRP421627
Published: 2024
cell line
gene, gene: overexpression, ...
bone cell, femur
osteosarcoma
Public Data
49 samples
Activation of hepatocyte growth factor (HGF)/MET signaling as a mechanism of acquired resistance to a novel YAP1/TEAD small molecule inhibitor.
Accession: SRP477446
Published: 2024 in Mol Cancer Ther
cell line, xenograft
bioactive entity
pleural effusion
mesothelioma
Public Data
27 samples
GEO accession GSE240386 is currently private and is scheduled to be released on Jun 10, 2024.
Accession: SRP454063
Published: 2024
cell line
gene, gene: crispr
brain, hindbrain